Center-Authored Papers

Filters: Author is Hsu, Katharine C  [Clear All Filters]
B
Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le Luduec J-B, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H et al..  2017.  KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016707059. Abstract
M
Madbouly A, Wang T, Haagenson M, Paunic V, Vierra-Green C, Fleischhauer K, Hsu KC, Verneris MR, Majhail NS, Lee SJ et al..  2017.  Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
S
Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg K-J, Muller C, Battiwalla M et al..  2015.  Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
V
Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, Petersdorf EW, Hsu KC.  2010.  Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.. Blood. 115(15):3162-5. Abstract
Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B et al..  2012.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.. The New England journal of medicine. 367(9):805-16. Abstract